Transcatheter Aortic Valve Replacement TAVR Market Synopsis:
In this report, LP Information studies the present scenario with the base year being 2017 and the growth prospects of global Transcatheter Aortic Valve Replacement TAVR market for 20182023.
Transcatheter Aortic Valve Replacement TAVR, also referred as Transcatheter Aortic Valve Implantation TAVI is a minimally invasive surgical procedure repairs the valve without removing the old, damaged valve. Instead, it wedges a replacement valve into the aortic valves place. Normally valve replacement method requires an open heart procedure with a sternotomy, in which the chest is surgically separated for the treatment. The TAVR procedures can be done through very small openings that leave all the chest bones in place.
The classification of Transcatheter Aortic Valve Replacement TAVR includes transfemoral approach, transapical approach and others. The proportion of transfemoral approach in 2016 is about 84%.
Transcatheter Aortic Valve Replacement TAVR is widely used for aortic stenosis, aortic regurgitation and other diseases. The most proportion of Transcatheter Aortic Valve Replacement TAVR is used for aortic regurgitation, and the proportion in 2016 is 75%.
Europe is the largest consumption place, with a consumption market share nearly 53% in 2016. Following Europe, North America is the second largest consumption place with the consumption market share of 40%.
Market competition is not intense. Edwards Lifesciences, Medtronic, St. Jude Medical, Boston Scientific, Meril Life Sciences, etc. are the leaders of the industry, and they hold key technologies and patents, with highend customers; have been formed in the monopoly position in the industry.
Over the next five years, LPILP Information projects that Transcatheter Aortic Valve Replacement TAVR will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.
This report presents a comprehensive overview, market shares and growth opportunities of Transcatheter Aortic Valve Replacement TAVR market by product type, application, key companies and key regions.
To calculate the market size, LP Information considers value generated from the sales of the following segments:
Segmentation by product type:
Transfemoral Approach
Transapical Approach
Segmentation by application:
Aortic Stenosis
Aortic Regurgitation
Other
We can also provide the customized separate regional or countrylevel reports, for the following regions:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
Edwards Lifesciences
Medtronic
St. Jude Medical
Boston Scientific
Meril Life Sciences
Bracco HLT
JenaValve Technology
…
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Transcatheter Aortic Valve Replacement TAVR market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Transcatheter Aortic Valve Replacement TAVR market by identifying its various subsegments.
Focuses on the key global Transcatheter Aortic Valve Replacement TAVR players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Transcatheter Aortic Valve Replacement TAVR with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market growth potential, opportunities, drivers, industryspecific challenges and risks.
To project the size of Transcatheter Aortic Valve Replacement TAVR submarkets, with respect to key regions along with their respective key countries.
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
